Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Bristol-Myers Squibb announced a strategic partnership...
Merck, known as MSD outside North America, has formally...
As the end of the year approaches, so does the annual...
Merck announced plans to build an Asia Research &...
Shanghai Fosun Pharma's on-again/off-again Hong Kong IPO...
Abcam, a UK maker of protein research tools, will pay...
Abcam will pay $170 million to buy Epitomics, a US mAb...
Shanghai Fosun Pharma has been given regulatory approval...
Over 700 industry leaders from the international...
Fosun Pharma’s long-in-the-works IPO on the Hong...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
